Foresite Capital Management V, LLC Diversified Active

Name: Foresite Capital Management V, LLC Q2 2026 13F Filing | 13F Explorer
Creator: Foresite Capital Management V, LLC
Published: 2026-08-14

Location: West Hollywood, CA

CIK: 0001792206 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $362M (100.0% shares, 0.0% debt)

Holdings (9)

ALMS ALUMIS INC. 45.8%

Value $166M Shares 5,896,995 Est. Cost — Unrealized —

CGON CG Oncology, Inc. 21.2%

Value $76.67M Shares 1,079,050 Est. Cost — Unrealized —

IRON Disc Medicine, Inc. 7.6%

Value $27.36M Shares 374,069 Est. Cost — Unrealized —

HIMS Hims & Hers Health, Inc. 7.1%

Value $25.59M Shares 738,151 Est. Cost — Unrealized —

PHVS Pharvaris N.V. 6.3%

Value $22.97M Shares 664,142 Est. Cost — Unrealized —

EIKN Eikon Therapeutics, Inc. 4.8%

Value $17.21M Shares 1,318,983 Est. Cost — Unrealized —

ODTX Odyssey Therapeutics, Inc. 3.7%

Value $13.34M Shares 713,105 Est. Cost — Unrealized —

LYEL Lyell Immunopharma, Inc. 1.8%

Value $6.693M Shares 476,386 Est. Cost — Unrealized —

NRIX Nurix Therapeutics, Inc. 1.8%

Value $6.429M Shares 265,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALMS	ALUMIS INC.	5,896,995	$166M	45.8%	—	—	COM	022307102
CGON	CG Oncology, Inc.	1,079,050	$76.67M	21.2%	—	—	COM	156944100
IRON	Disc Medicine, Inc.	374,069	$27.36M	7.6%	—	—	COM	254604101
HIMS	Hims & Hers Health, Inc.	738,151	$25.59M	7.1%	—	—	COM CL A	433000106
PHVS	Pharvaris N.V.	664,142	$22.97M	6.3%	—	—	COM	N69605108
EIKN	Eikon Therapeutics, Inc.	1,318,983	$17.21M	4.8%	—	—	COM	282564103
ODTX	Odyssey Therapeutics, Inc.	713,105	$13.34M	3.7%	—	—	COM	67613T104
LYEL	Lyell Immunopharma, Inc.	476,386	$6.693M	1.8%	—	—	COM	55083R203
NRIX	Nurix Therapeutics, Inc.	265,000	$6.429M	1.8%	—	—	COM	67080M103